Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke: A multicenter, randomized, open-label phase II trial.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Glucose intolerance
- Focus Adverse reactions; Therapeutic Use
- Acronyms MAAS
- 14 Jul 2012 Actual initiation date (4 Jul 2012) added as reported by European Clinical Trials Database record.
- 14 Jul 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005980-26).
- 04 Jul 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database record.